Cytokinetics, Incorporated company logo
Cytokinetics, Incorporated logo

Cytokinetics, Incorporated (CYTK) Cash and Cash Equivalents

Annual Cash & Cash Equivalents

$1.08B$461.19M+74.97%

Summary

Current Value
As of today, CYTK annual cash & cash equivalents is $1.08B, up +74.97% on
Historical Performance
CYTK annual cash & cash equivalents is up +128.22% over the past 3 years, and up +378.16% over the past 5 years
All-Time High Comparison
CYTK annual cash & cash equivalents is currently at its all-time high
3-Year Low Comparison
CYTK annual cash & cash equivalents is +74.97% above its 3-year low of $615.20M reached on
Sector Comparison
CYTK annual cash & cash equivalents is higher than 93.90% of companies in Healthcare sector

Cash and Cash Equivalents Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

CYTK Performance
MetricDateValue1Y3Y5Y15Y
Annual Cash & Cash Equivalents$1.08B+75.0%+128.2%+378.2%+838.2%
Quarterly Cash & Cash Equivalents$965.65M-4.6%+11.3%+135.4%
Price$63.32+33.7%+46.7%+193.8%+412.3%
Annual Current Assets$1.11B+76.4%+106.8%+374.0%+847.6%
Annual Total Liabilities$1.54B+27.0%+157.3%+411.1%+7160.1%
Annual Working Capital$928.27M+76.7%+100.1%+346.9%+859.6%
Annual Net Income-$589.53M-12.0%-173.8%-384.4%-2501.9%

Cash and Cash Equivalents Highs

CYTK Annual Cash & Cash Equivalents Highs Comparison
PeriodHighDateCurrent
3Y$1.08Bat high
5Y$1.08Bat high
All$1.08Bat high

Cash and Cash Equivalents Lows

CYTK Annual Cash & Cash Equivalents Lows Comparison
PeriodLowDateCurrent
3Y$615.20M+75.0%
5Y$464.06MN/A+131.9%
All$49.02M+2095.7%

Cash and Cash Equivalents History

YearValueChange
$1.08B+75.0%
$615.20M-21.4%
$782.58M+65.9%
$471.64M+1.6%
$464.06M+106.1%
$225.11M+13.3%
YearValueChange
$198.73M-26.1%
$268.89M+72.1%
$156.25M+40.2%
$111.44M+33.9%
$83.23M-

FAQ

  • What is the current annual cash & cash equivalents of CYTK?

    As of today, CYTK annual cash & cash equivalents is $1.08B

  • What is 1-year change in CYTK annual cash & cash equivalents?

    CYTK annual cash & cash equivalents is up +74.97% year-over-year

  • What is 3-year change in CYTK annual cash & cash equivalents?

    CYTK annual cash & cash equivalents is up +128.22% over the past 3 years

  • How far is CYTK annual cash & cash equivalents from its all-time high?

    CYTK annual cash & cash equivalents is currently at its all-time high

  • How does CYTK annual cash & cash equivalents rank versus sector peers?

    CYTK annual cash & cash equivalents is higher than 93.90% of companies in Healthcare sector

  • When is CYTK next annual earnings release?

    The next annual earnings release for CYTK is on

Cash and Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

Data Sources & References

  1. CYTK Official Website www.cytokinetics.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1061983/000119312525267059/0001193125-25-267059-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1061983/000095017025029206/0000950170-25-029206-index.htm
  4. CYTK Profile on Yahoo Finance finance.yahoo.com/quote/CYTK
  5. CYTK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/cytk